K279-1154 Screening compound: 2-({3-[2-(CYCLOHEXYLAMINO)-2-OXOETHYL]-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL}SULFANYL)-N~1~-(4-ETHYLPHENYL)ACETAMIDE

K279-1154 Screening compound: 2-({3-[2-(CYCLOHEXYLAMINO)-2-OXOETHYL]-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL}SULFANYL)-N~1~-(4-ETHYLPHENYL)ACETAMIDE
K279-1154 Screening compound: 2-({3-[2-(CYCLOHEXYLAMINO)-2-OXOETHYL]-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL}SULFANYL)-N~1~-(4-ETHYLPHENYL)ACETAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound K279-1154
2-({3-[2-(CYCLOHEXYLAMINO)-2-OXOETHYL]-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL}SULFANYL)-N~1~-(4-ETHYLPHENYL)ACETAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K279-1154

Molecular Formula

C28H31N5O3S (C28 H31 N5 O3 S)

Compound Name

2-({3-[2-(CYCLOHEXYLAMINO)-2-OXOETHYL]-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL}SULFANYL)-N~1~-(4-ETHYLPHENYL)ACETAMIDE

IUPAC name

n/a

SMILES

CCc(cc1)ccc1NC(CSC(N1C2CC(NC3CCCCC3)=O)=Nc(cccc3)c3C1=NC2=O)=O

InChI

InChI=1S/C28H31N5O3S/c1-2-18-12-14-20(15-13-18)30-25(35)17-37-28-31-22-11-7-6-10-21(22)26-32-27(36)23(33(26)28)16-24(34)29-19-8-4-3-5-9-19/h6-7,10-15,19,23H,2-5,8-9,16-17H2,1H3,(H,29,34)(H,30,35)/t23-/m0/s1

InChI Key

GRLHPNIPBILDDO-QHCPKHFHSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

517.65

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.170

Distribution Coefficient, logD

4.168

Water Solubility, LogSw

-4.25

Polar Surface Area

82.498

Acid Dissociation Constant (pKa)

11.05

Base Dissociation Constant (pKb)

4.86

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

39.30

K279-1154 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

ACE2 Library (3043 compounds)

CNS targets activity set (6557 compounds)

CORONAVIRUS Library (20774 compounds)

Regenerative Medicine Focused Library (23016 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds

References: we are preparing a list of scientific research reports with K279-1154 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K279-1154?
Check Price and Availability of K279-1154, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K279-1154 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K279-1154
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K279-1154
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K279-1154 available by request